 | 
|
| |
|
Titel: Sänkt livskvalitet vid skov grundar för alternativ terapi (serie: Tema kronisk tarminflammation) 2009 nr 45 sid 3010-3
|
Referenser:
[1]Guyatt GH, Thompson PJ, Berman LB, Sullivan MJ, Townsend M, Jones NL, et al. How should we measure function in patients with chronic heart and lung disease? J Chronic Dis. 1985; 38(6): 517-24.
[2]Hjortswang H, Almer S, Strom M. The network: a strategy to describe the relationship between quality of life and disease activity. The case of inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1999; 11(10): 1099-104.
[3] Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995; 273(1): 59-65.
[4] Wiklund I, Dimenäs E, Wahl M. Factors of importance when evaluating quality of life in clinical trials. Control Clin Trials. 1990;11: 169-179
[5] Ware Jr. JE, Sherbourne CD. The MOS 36-item Short-Form health Survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-481.
[6] Mitchell A, Guyatt G, Singer J, Irvine EJ, Goodacre R, Tompkins C, et al. Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol. 1988;10:306-310
[7] Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A, et al. Quality of life: a valid and reliable measure of the therapeutic efficacy in the treatment of inflammatory bowel disease. Gastroenterology. 1994;106:287-296
[8] Drossman DA, Leserman J, Li ZM, Mitchell CM, Zagami EA, Patrick DL. The rating form of IBD patient concerns: a new measure of health status. Psychosom Med. 1991; 56(6): 701-12.
[9]Sullivan M, Karlsson J, Wre Jr. JE. The Swedish SF-36 Health Survey I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med. 1995;10:1349-1358
[10] Hjortswang H, Järnerot G, Curman B, Sandberg-Gertzén H, Tysk C, Blomberg B, et al. Validation of the inflammatory bowel disease questionnaire in Swedish patients with ulcerative colitis. Scand J Gastroenterol. 2001;36:77-85
[11] Stjernman H, Grännö C, Bodemar G, Järnerot G, Ockander L, Tysk C, et al. Evaluation of the Inflammatory Bowel Disease Questionnaire in Swedish patients with Crohns disease: Scand J Gastroenterol. 2006;41:934-943
[12] Hjortswang H, Ström M, Almeida R, Almer S. Evaluation of the RFIPC, a disease-specific health-related quality of life questionnaire, in Swedish patients with ulcerative colitis. Scand J Gastroenterol. 1997;32:1235-40
[13] Hjortswang H, Järnerot G, Curman B, Sandberg-Gertzén H, Tysk C, Blomberg B, et al. Short Health Scale: a valid measure of subjective health in ulcerative colitis. Scand J Gastroenterol. 2006;41:1196-203
[14] Stjernman H, Grännö C, Järnerot G, Ockander L, Tysk C, Blomberg B, et al. Short Health Scale: a valid, reliable, and responsive instrument for subjective health assessment in Crohn's disease. Inflamm Bowel Dis. 2008;14:47-52
[15]Hjortswang H, Järnerot G, Curman B, Sandberg-Gertzén H, Tysk C, Blomberg B, et al. The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis. Eur J Gastroenterol Hepatol. 2003; 15(9): 1011-20.
[16]Andersson P, Olaison G, Bendtsen P, Myrelid P, Sjodahl R. Health related quality of life in Crohns proctocolitis does not differ from a general population when in remission. Colorectal Disease. 2003; 5(1): 56-62.
[17]Hjortswang H, Tysk C, Bohr J, Benoni C, Vigren L, Kilander A, et al. Health-related quality of life in collagenous colitis. Submitted.
[18]Casellas F, Arenas JI, Baudet JS, Fábregas S, García N, Gelabert J, et al. Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis. 2005; 11(5): 488-96.
[19]Casellas F, Lopez-Vivancos J, Badia X, Vilaseca J, Malagelada JR. Impact of surgery for Crohns disease on health-related quality of life. Am J Gastroenterol. 2000; 95(1): 177-82.
[20]Bernklev T, Jahnsen J, Aadland E, Sauar J, Schulz T, Lygren I, et al. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol. 2004; 39(4): 365-73.
[21]Robinson A, Thompson DG, Wilkin D, Roberts C, Northwest Gastrointestinal Research G. Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial.[see comment]. Lancet. 2001; 358(9286): 976-81.
[22]Waters BM, Jensen L, Fedorak RN. Effects of formal education for patients with inflammatory bowel disease: a randomized controlled trial. Can J Gastroenterol. 2005; 19(4): 235-44.
[23]Oxelmark L, Magnusson A, Löfberg R, Hillerås P. Group-based Intervention Program in Inflammatory Bowel Disease Patients: Effects on Quality of Life. Inflamm Bowel Dis. 2007; 13(2): 182-90.
[24]von Wietersheim J, Kessler H. Psychotherapy with chronic inflammatory bowel disease patients: a review. Inflamm Bowel Dis. 2006; 12(12): 1175-84.
[25]Moskovitz DN, Maunder RG, Cohen Z, McLeod RS, MacRae H. Coping behavior and social support contribute independently to quality of life after surgery for inflammatory bowel disease. Dis Colon & Rectum. 2000; 43(4): 517-21.
[26]WHO. Legal Status of Traditional Medicine and Complementary/Alternative Medicine. In: A Worldwide Review ed.^eds.: WHO Unit on Traditional Medicine 2002:182.
[27]Rawsthorne P, Shanahan F, Cronin NC, Anton PA, Löfberg R, Bohman L, et al. An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease. Am J Gastroenterol. 1999; 94(5): 1298-303.
[28]Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993; 328(4): 246-52.
[29]Ernst E, Pittler MH, Wider B. The Desktop Guide to Complementary and Alternative Medicine. An evidence-based approach. ed.^eds. 2nd ed. Philadelphia: Mosby Elsevier 2006:556.
[30]Langmead L, Rampton D. Review article: complementary and alternative therapies for inflammatory bowel disease. APT. 2006; 23(3): 341-9.
[31]Joos S, Brinkhaus B, Maluche C, Maupai N, Kohnen R, Kraehmer N, et al. Acupuncture and moxibustion in the treatment of active Crohns disease: a randomized controlled study. Digestion. 2004; 69(3): 131-9.
[32]Joos S, Wildau N, Kohnen R, Szecsenyi J, Schuppan D, Willich SN, et al. Acupuncture and moxibustion in the treatment of ulcerative colitis: a randomized controlled study. Scand J Gastroenterol. 2006; 41(9): 1056-63.
[33]Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as »Curecumin«: from kitchen to clinic. Biochem Pharmacol. 2008; 75(4): 787-809.
[34]Stadlbauer V, Fickert P, Lackner C, Schmerlaib J, Krisper P, Trauner M, et al. Hepatotoxicity of NONI juice: report of two cases. World Journal of Gastroenterology. 2005; 11(30): 4758-60.
[35]Bodeker G, Ong C, Grundy C, Burford G, Shein K. WHO Global Atlas of Traditional, Complementary and Alternative Medicine. Kobe: World Health Organization, the Center for Health Development, 2005, p. 216.
[36]Jensen I, Lekander M, Nord C, Rane A, Ekenryd C. Complementary and Alternative Medicine (CAM). A Systematic review of Intervention Research in Sweden. Jensen I, ed.^eds. Stockholm: FAS. Forskningsrådet för Arbetsliv och Social Vetenskap. Swedish Council for Working Life and Social Research 2007:46.
 3010 |
 3011 |
 3012 |
 3013 |